Abstract
IL2 production in response to phytohemagglutinin (PHA) was measured in 5 patients with growth hormone deficiency (GHD) (ages 7.8-14.5). In 3 patients IL2 was determined before and 24 hrs after the first dose (2 units) of human growth hormone (HGH) administration. In 2 patients IL2 was measured after 1 and 16 months of HGH treatment. At no time could IL2 production be identified in these patients. In contrast 1 patient (age 14) with short stature and normal GH responses to standard stimulatory tests on treatment with exogenous HGH for 6 months did produce IL2 normally.
We have previously presented data (Society Pediatric Research 1984) demonstrating that continuous treatment with HGH for 1 year resulted in transient decrease in % B cells, T helper/suppressor (T H/S) ratio and PHA responsiveness in 8 GHD patients. When treatment was interrupted for 1-2 month intervals, restarting HGH resulted in a fall in % B cells in 5/7 patients, mean 17.6% (range 12-20) to 7.8% (range 6-11) and a fall in T H/S ratio in 4/7 patients, mean 1.83 (range 1.5-2.0) to 1.20 (range 1.0-1.4) after 1-2 months of treatment. Serum immunoglobulins and poly-morphonuclear leukocyte function was not affected by HGH treatment for up to 24 months in any patient.
In conclusion Interleukin 2 production, unlike other immune parameters, is impaired in growth hormone deficient patients and is unaffected by human growth hormone treatment.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rapaport, R., Oleske, J., Schenkman, S. et al. 58 GROWTH HORMONE DEFICIENCY: INTERLEUKIN 2 (IL2) AND IMMUNE FUNCTION. Pediatr Res 19, 613 (1985). https://doi.org/10.1203/00006450-198506000-00078
Issue Date:
DOI: https://doi.org/10.1203/00006450-198506000-00078